Authors: Pizzocaro, G Piva, L Colavita, M Ferri, S Artusi, R Boracchi, P Parmiani, G Marubini, E

Citation: G. Pizzocaro et al., Interferon adjuvant to radical nephrectomy in Robson stages II and III renal cell carcinoma: A multicentric randomized study, J CL ONCOL, 19(2), 2001, pp. 425-431

Authors: Fizazi, K Tjulandin, S Salvioni, R Germa-Lluch, JR Bouzy, J Ragan, D Bokemeyer, C Gerl, A Flechon, A de Bono, JS Stenning, S Horwich, A Pont, J Albers, P De Giorgi, U Bower, M Bulanov, A Pizzocaro, G Aparicio, J Nichols, CR Theodore, C Hartmann, JT Schmoll, HJ Kaye, SB Culine, S Droz, JP Mahe, C

Citation: K. Fizazi et al., Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: Prognostic factors and role of postsurgery chemotherapy-results from an international study group, J CL ONCOL, 19(10), 2001, pp. 2647-2657

Authors: Laguna, MP Pizzocaro, G Klepp, O Algaba, F Kisbenedek, L Leiva, O

Citation: Mp. Laguna et al., EAU guidelines on testicular cancer, EUR UROL, 40(2), 2001, pp. 102-110

Authors: Fauser, AA Pizzocaro, G Schueller, J Khayat, D Wilkinson, P

Citation: Aa. Fauser et al., A double-blind, randomised, parallel study comparing intravenous dolasetron plus dexamethasone and intravenous dolasetron alone for the management offractionated cisplatin-related nausea and vomiting, SUPP CARE C, 8(1), 2000, pp. 49-54

Authors: Locatelli, MC Facendola, G Pizzocaro, G Piva, L Pegoraro, C Pallavicini, EB Signaroldi, A Meregalli, M Lombardi, F Beretta, GD Scanzi, F Labianca, R Dallavalle, G Luporini, G

Citation: Mc. Locatelli et al., Subcutaneous administration of interleukin-2 and interferon-alpha 2b in advanced renal cell carcinoma: Long-term results, CANCER DET, 23(2), 1999, pp. 172-176